Enriching the therapeutic armamentarium for IBD - Université de Lorraine Accéder directement au contenu
Article Dans Une Revue Nature reviews. Gastroenterology & hepatology Année : 2014

Enriching the therapeutic armamentarium for IBD

Résumé

In 2013, several new IBD drugs, including golimumab and vedolizumab, have been approved or completed successful programmes, showing efficacy in both Crohn’s disease and ulcerative colitis. In addition, classic IBD drugs have been formulated for colonic delivery, such as budesonide MMX®, which was recently approved for mild-to-moderate ulcerative colitis.
Fichier non déposé

Dates et versions

hal-01688810 , version 1 (19-01-2018)

Identifiants

Citer

Silvio Danese, Laurent Peyrin-Biroulet. Enriching the therapeutic armamentarium for IBD. Nature reviews. Gastroenterology & hepatology, 2014, 11 (2), pp.84 - 86. ⟨10.1038/nrgastro.2013.246⟩. ⟨hal-01688810⟩
11 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More